Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

M.V. Corrias, S. Parodi, A. Tchirkov, T. Lammens, A. Vicha, C. Pasqualini, C. Träger, Y. Yáñez, S. Dallorso, L. Varesio, R. Luksch, G. Laureys, D. Valteau-Couanet, A. Canete, U. Pöetschger, R. Ladenstein, S.A. Burchill

Research output: Contribution to journalArticle

Cite this

Corrias, M. V., Parodi, S., Tchirkov, A., Lammens, T., Vicha, A., Pasqualini, C., Träger, C., Yáñez, Y., Dallorso, S., Varesio, L., Luksch, R., Laureys, G., Valteau-Couanet, D., Canete, A., Pöetschger, U., Ladenstein, R., & Burchill, S. A. (2018). Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. Pediatric Blood and Cancer, 65(7). https://doi.org/10.1002/pbc.27052